Literature DB >> 7710718

Autoimmunity in the eye and its regulation.

I Gery1, J W Streilein.   

Abstract

Recent studies have provided new information concerning the development of autoimmune-mediated intraocular inflammation (uveitis) and the mechanisms that suppress this sight-robbing process. Newly collected data have led to several interesting advances: the discovery of additional uveitogenic antigens and novel uveitogenic reactions; dissection of the early steps of the pathogenic process; identification of the subsets of lymphocytes that selectively accumulate in the inflamed eye; analysis of the development of tolerance against sequestered antigens in the eye; elucidation of the cellular and molecular events of the anterior chamber-associated immune deviation, the major immunoregulatory mechanism in the eye; the capacity of this mechanism to inhibit and even treat uveitis; and examination of the mechanisms whereby oral tolerance inhibits ocular inflammation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7710718     DOI: 10.1016/0952-7915(94)90017-5

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  11 in total

1.  Macrophages and MHC class II positive cells in the choroid during endotoxin induced uveitis.

Authors:  P Yang; A F de Vos; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1997-05       Impact factor: 4.638

Review 2.  Tolerance and autoimmunity in the eye: a role for CD8 T cells in organ-specific autoimmunity in the retina.

Authors:  John V Forrester; Richard J Cornall
Journal:  Immunology       Date:  2003-11       Impact factor: 7.397

Review 3.  Understanding the role of aldose reductase in ocular inflammation.

Authors:  U C S Yadav; S K Srivastava; K V Ramana
Journal:  Curr Mol Med       Date:  2010-08       Impact factor: 2.222

4.  Retinal laser burn disrupts immune privilege in the eye.

Authors:  Hong Qiao; Kenyatta Lucas; Joan Stein-Streilein
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

5.  Lymphocyte subsets and ocular inflammation: future prospects for immune deviation therapy?

Authors:  A Kijlstra
Journal:  Br J Ophthalmol       Date:  1996-11       Impact factor: 4.638

Review 6.  Cytokines in posterior uveitis: an update.

Authors:  V K Singh; G Rai
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

7.  Combined cyclosporin-A /prednisone therapy of patients with active uveitis suppresses IFN-gamma production and the function of dendritic cells.

Authors:  M A Frassanito; R Dammacco; T Fusaro; A Cusmai; S Guerriero; C Sborgia
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

8.  Understanding autoimmunity in the eye: from animal models to novel therapies.

Authors:  Rachel R Caspi
Journal:  Discov Med       Date:  2014-03       Impact factor: 2.970

9.  Adoptive transfer of immune cells from glaucomatous mice provokes retinal ganglion cell loss in recipients.

Authors:  Oliver W Gramlich; Qiong J Ding; Wei Zhu; Amy Cook; Michael G Anderson; Markus H Kuehn
Journal:  Acta Neuropathol Commun       Date:  2015-09-15       Impact factor: 7.801

10.  An immunologically privileged retinal antigen elicits tolerance: major role for central selection mechanisms.

Authors:  Dody Avichezer; Rafael S Grajewski; Chi-Chao Chan; Mary J Mattapallil; Phyllis B Silver; James A Raber; Gregory I Liou; Barbara Wiggert; Giavonni M Lewis; Larry A Donoso; Rachel R Caspi
Journal:  J Exp Med       Date:  2003-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.